These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 162674)

  • 1. Clinical study on the efficacy of O-(beta-hydroxyethyl)rutoside (HR) in varicosis of pregnancy.
    Bergstein NA
    J Int Med Res; 1975; 3(3):189-93. PubMed ID: 162674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of beta-hydroxyethylrutoside in patients with varicose veins in pregnancy].
    Sohn C; Jähnichen C; Bastert G
    Zentralbl Gynakol; 1995; 117(4):190-7. PubMed ID: 7778354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial of hydroxyethylrutosides in the treatment of haemorrhoids of pregnancy.
    Wijayanegara H; Mose JC; Achmad L; Sobarna R; Permadi W
    J Int Med Res; 1992 Feb; 20(1):54-60. PubMed ID: 1568520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and rheological efficacy of troxerutin in obstetric gynecology].
    Marhic C
    Rev Fr Gynecol Obstet; 1991 Feb; 86(2 Pt 2):209-12. PubMed ID: 1767176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the activity of a flavonoid, 3-(beta-hydroxyethyl)-rutoside, at high dose levels on venous tone measured by "strain gauge" plethylsmography.
    Forconi S; Guerrini M; Di Perri T
    Vasa; 1977; 6(3):279-84. PubMed ID: 335696
    [No Abstract]   [Full Text] [Related]  

  • 6. An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
    Beltramino R; Penenory A; Buceta AM
    Int Angiol; 1999 Dec; 18(4):337-42. PubMed ID: 10811525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of large doses of a flavonoid O-(betahydroxyethyl)-rutoside on some aspects of venous circulation].
    Forconi S; Guerrini M
    Clin Ter; 1977 Feb; 80(3):229-55. PubMed ID: 852233
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pregnancy varicosis, drug prevention and therapy].
    Schmid W
    Fortschr Med; 1972 Dec; 90(34):1279-80. PubMed ID: 4573909
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy and complications of pregnancy varicosis in clinical experiments].
    Mauss HJ
    Zentralbl Gynakol; 1973 Jul; 95(27):904-10. PubMed ID: 4582355
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
    Bergqvist D; Hallböök T; Lindblad B; Lindhagen A
    Vasa; 1981; 10(3):253-60. PubMed ID: 7025500
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modifications induced by long-term treatment with high doses of 0-(beta-hydroxyethyl)-rutoside in chronic venous insufficiency].
    Barbarino C; Pezzangora V
    Vasa Suppl; 1989; 27():120. PubMed ID: 2623482
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability.
    MacLennan WJ; Wilson J; Rattenhuber V; Dikland WJ; Vanderdonckt J; Moriau M
    Gerontology; 1994; 40(1):45-52. PubMed ID: 8034203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of edema and flight microangiopathy with Venoruton (HR), (0-[beta-hydroxyethyl]-rutosides) in patients with varicose veins.
    Cesarone MR; Belcaro G; Ricci A; Brandolini R; Pellegrini L; Dugall M; Di Renzo A; Vinciguerra G; Gizzi G; Cornelli U; Errichi BM; Corsi M; Ippolito E; Adovasio R; Cacchio M; Stuard S; Larnier C; Candiani C; Cerritelli F
    Angiology; 2005; 56(3):289-93. PubMed ID: 15889196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Percutaneous digitalis therapy of the varicose symptoms complex in pregnancy].
    Keller J
    Zentralbl Gynakol; 1971 Feb; 93(8):251-3. PubMed ID: 5132789
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
    Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T
    Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of O-(beta-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat.
    Dobyan DC; Bull JM; Strebel FR; Sunderland BA; Bulger RE
    Lab Invest; 1986 Nov; 55(5):557-63. PubMed ID: 3773477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of O-(beta-hydroxyethyl)-rutoside on the glucose metabolism of cultured human varicose saphenous veins.
    Matagne D; Gilles R
    Arch Int Physiol Biochim; 1977 Feb; 85(1):133-8. PubMed ID: 68718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
    Pedersen FM; Hamberg O; Sørensen MD; Neland K
    Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double blind three center clinical trial on the short-term efficacy of 0-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome.
    de Jongste AB; Jonker JJ; Huisman MV; ten Cate JW; Azar AJ
    Thromb Haemost; 1989 Nov; 62(3):826-9. PubMed ID: 2688186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical clarification of the effects of rutin derivatives].
    Kappert A
    Angiologica; 1972; 9(3-6):401-7. PubMed ID: 4669477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.